Communicable Diseases

Abstract

Globally, infectious diseases often disproportionately affect women, and have implications for the health of future generations. The human immunodeficiency virus (HIV), tuberculosis, malaria, and schistosomiasis are four such pathogens. Infection with these organisms has a broad impact on maternal child health in many areas of the developing world, and global initiatives to control these diseases will significantly improve the health of generations to come.

Keywords

malaria - tuberculosis - HIV - schistosomiasis - women's health - global health - pregnancy

• References

• 1 UNAIDS. UNAIDS Report on the Global AIDS Epidemic. UNAIDS; 2013
• 2 HIV in Women: Centers for Disease Control and Prevention. Available at: http://www.cdc.gov/hiv/pdf/risk_women.pdf . Accessed on November 14, 2014
• 3 Dunkle KL, Jewkes RK, Brown HC, Gray GE, McIntryre JA, Harlow SD. Gender-based violence, relationship power, and risk of HIV infection in women attending antenatal clinics in South Africa. Lancet 2004; 363 (9419) 1415-1421
• 4 Maman S, Mbwambo JK, Hogan NM , et al. HIV-positive women report more lifetime partner violence: findings from a voluntary counseling and testing clinic in Dar es Salaam, Tanzania. Am J Public Health 2002; 92 (8) 1331-1337
• 5 Fonck K, Leye E, Kidula N, Ndinya-Achola J, Temmerman M. Increased risk of HIV in women experiencing physical partner violence in Nairobi, Kenya. AIDS Behav 2005; 9 (3) 335-339
• 6 Jewkes R, Nduna M, Levin J , et al. A cluster randomized-controlled trial to determine the effectiveness of Stepping Stones in preventing HIV infections and promoting safer sexual behaviour amongst youth in the rural Eastern Cape, South Africa: trial design, methods and baseline findings. Trop Med Int Health 2006; 11 (1) 3-16
• 7 Cohen MS, Chen YQ, McCauley M , et al; HPTN 052 Study Team. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011; 365 (6) 493-505
• 8 Grant RM, Lama JR, Anderson PL , et al; iPrEx Study Team. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 2010; 363 (27) 2587-2599
• 9 Choopanya K, Martin M, Suntharasamai P , et al; Bangkok Tenofovir Study Group. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet 2013; 381 (9883) 2083-2090
• 10 WHO. The Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach. WHO; 2013
• 11 Zaba B, Calvert C, Marston M , et al. Effect of HIV infection on pregnancy-related mortality in sub-Saharan Africa: secondary analyses of pooled community-based data from the network for Analysing Longitudinal Population-based HIV/AIDS data on Africa (ALPHA). Lancet 2013; 381 (9879) 1763-1771
• 12 Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. 2012. Available at: http://aidsinfo.nih.gov/contentfiles/lvguidelines/PerinatalGL . Accessed on November 14, 2014
• 13 Centers for Disease Control and Prevention. Facts about malaria. Available at: http://www.cdc.gov/malaria/about/facts.html . Accessed on November 14, 2014
• 14 World Health Organization, World Malaria Report—2011. Available at: http://www.who.int/malaria/world_malaria_report_2011/burdenestimatesbriefing2011.pdf . Accessed on November 14, 2014
• 15 Ofori M, Ansah E, Agyepong I, Ofori-Adjei D, Hviid L, Akanmori B. Pregnancy-associated malaria in a rural community of Ghana. Ghana Med J 2009; 43 (1) 13-18
• 16 Schantz-Dunn J, Nour NM. Malaria and pregnancy: a global health perspective. Rev Obstet Gynecol 2009; 2 (3) 186-192
• 17 Garner P, Gülmezoglu AM. Drugs for preventing malaria in pregnant women. Cochrane Database Syst Rev 2006; (4) CD000169
• 18 Kiwuwa MS, Mufubenga P. Use of antenatal care, maternity services, intermittent presumptive treatment and insecticide treated bed nets by pregnant women in Luwero district, Uganda. Malar J 2008; 7: 44
• 19 Orton LC, Omari AAA. Drugs for treating uncomplicated malaria in pregnant women. Cochrane Database Syst Rev 2008; (4) CD004912
• 20 Status Report on Artemisinin Resistance, January 2014. Available at: http://www.who.int/malaria/publications/atoz/status_rep_artemisinin_resistance_jan2014.pdf . Accessed on November 14, 2014
• 21 CDC | TB | Data and Statistics. Available at: http://www.cdc.gov/tb/statistics/default.htm . Accessed on November 14, 2014
• 22 World Health Organization. Tuberculosis in Women. (2014). Available at: www.who.int/tb/challenges/hiv/tb_women_factsheet.pdf . Accessed on November 19, 2014
• 23 Hamadeh MA, Glassroth J. Tuberculosis and pregnancy. Chest 1992; 101 (4) 1114-1120
• 24 Good Jr JT, Iseman MD, Davidson PT, Lakshminarayan S, Sahn SA. Tuberculosis in association with pregnancy. Am J Obstet Gynecol 1981; 140 (5) 492-498
• 25 Carter EJ, Mates S. Tuberculosis during pregnancy. The Rhode Island experience, 1987 to 1991. Chest 1994; 106 (5) 1466-1470
• 26 Zenner D, Kruijshaar ME, Andrews N, Abubakar I. Risk of tuberculosis in pregnancy: a national, primary care-based cohort and self-controlled case series study. Am J Respir Crit Care Med 2012; 185 (7) 779-784
• 27 Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR 2000; 49 (No. RR-6).
• 28 Latent tuberculosis: a guide for primary health care providers. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for HIV/AIDS, viral hepatitis, STD and TB prevention, Division of Tuberculosis Prevention, Atlanta, Georgia. 2013. Available at: www.cdc.gov/tb/publications/ltbi/pdf/TargetedLTBI.pdf . Accessed on November 14, 2014
• 29 Schaefer G. Female genital tuberculosis. Clin Obstet Gynecol 1976; 19 (1) 223-239
• 30 Muir DG, Belsey MA. Pelvic inflammatory disease and its consequences in the developing world. Am J Obstet Gynecol 1980; 138 (7, Pt 2): 913-928
• 31 Ghosh K, Ghosh K, Chowdhury JR. Tuberculosis and female reproductive health. J Postgrad Med 2011; 57 (4) 307-313
• 32 Bothamley G. Drug treatment for tuberculosis during pregnancy: safety considerations. Drug Saf 2001; 24 (7) 553-565
• 33 Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings. Available at: http://whqlibdoc.who.int/publications/2011/9789241500708_eng.pdf . Accessed on November 14, 2014
• 34 Hotez P, Whitham M. Helminth infections: a new global women's health agenda. Obstet Gynecol 2014; 123 (1) 155-160
• 35 WHO Schistosomiasis. Available at: http://www.who.int/mediacentre/factsheets/fs115/en/ . Accessed on November 14, 2014
• 36 Friedman JF, Mital P, Kanzaria HK, Olds GR, Kurtis JD. Schistosomiasis and pregnancy. Trends Parasitol 2007; 23 (4) 159-164
• 37 Coutinho HM, McGarvey ST, Acosta LP , et al. Nutritional status and serum cytokine profiles in children, adolescents, and young adults with Schistosoma japonicum-associated hepatic fibrosis, in Leyte, Philippines. J Infect Dis 2005; 192 (3) 528-536
• 38 Friedman JF, Kanzaria HK, Acosta LP , et al. Relationship between Schistosoma japonicum and nutritional status among children and young adults in Leyte, the Philippines. Am J Trop Med Hyg 2005; 72 (5) 527-533
• 39 Friedman JF, Kanzaria HK, McGarvey ST. Human schistosomiasis and anemia: the relationship and potential mechanisms. Trends Parasitol 2005; 21 (8) 386-392
• 40 Moormann AM, Sullivan AD, Rochford RA , et al. Malaria and pregnancy: placental cytokine expression and its relationship to intrauterine growth retardation. J Infect Dis 1999; 180 (6) 1987-1993
• 41 Kurtis JD, Higashi A, Wu HW , et al. Maternal Schistosomiasis japonica is associated with maternal, placental, and fetal inflammation. Infect Immun 2011; 79 (3) 1254-1261
• 42 McDonald EA, Pond-Tor S, Jarilla B , et al. Schistosomiasis japonica during pregnancy is associated with elevated endotoxin levels in maternal and placental compartments. J Infect Dis 2014; 209 (3) 468-472
• 43 Allen HE, Crompton DWT, de Silva N, LoVerde PT, Olds GR. New policies for using anthelmintics in high risk groups. Trends Parasitol 2002; 18 (9) 381-382